Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
- 17 June 2005
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 365 (9477), 2105-2115
- https://doi.org/10.1016/S0140-6736(05)66553-1
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytomegalovirus-seropositive donorsTransplantation, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipientsTransplantation, 2003
- A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantationTransplant International, 2002
- High‐dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patientsTransplant Infectious Disease, 1999
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationThe New England Journal of Medicine, 1999
- Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipientsTransplant International, 1997
- Cytomegalovirus (CMV) prophylaxis by acyclovir in pre-transplant CMV-positive renal transplant recipientsTransplant International, 1994
- Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adultsJournal of Medical Virology, 1993
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsThe New England Journal of Medicine, 1989